TAK logo

TAK Total Costs & Expenses

Latest reported¥4.15T JPY
TAK TTM Total Costs & Expenses · JPY (¥1.06T → ¥4.15T)
High-resolution chart · PNG

TAK total costs & expenses history

Trailing twelve months (TTM) · JPY. Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Total Costs & Expenses — Trailing twelve months (TTM) (JPY)
Period endingTotal Costs & Expenses (JPY)
4,148,539,366,000
4,052,175,366,000
4,113,368,086,000
4,171,402,000,000
4,119,392,000,000
4,238,934,000,000
4,171,572,000,000
4,100,662,000,000
4,201,303,000,000
4,049,689,000,000
3,856,343,000,000
3,799,632,000,000
3,605,070,000,000
3,536,972,000,000
3,544,287,000,000
3,379,535,000,000
3,229,057,000,000
3,108,159,000,000
2,852,986,000,000
2,761,789,000,000
2,755,029,000,000
2,688,543,000,000
2,902,647,000,000
3,014,841,000,000
3,044,813,000,000
3,249,503,000,000
3,256,931,000,000
2,838,063,000,000
2,425,150,000,000
1,936,859,000,000
1,577,054,000,000
1,590,328,000,000
1,626,439,000,000
1,528,740,000,000
1,525,047,000,000
1,534,525,000,000
1,548,375,000,000
1,576,182,000,000
1,549,188,000,000
1,571,676,000,000
1,560,888,000,000
1,676,553,000,000
1,991,924,000,000
1,966,022,000,000
1,956,355,000,000
1,907,078,000,000
1,575,827,000,000
1,561,585,000,000
1,539,424,000,000
1,554,561,000,000
1,515,992,000,000
1,791,658,000,000
1,615,168,000,000
1,434,762,000,000
1,787,585,000,000
1,336,076,000,000
1,289,481,000,000
1,243,905,000,000
1,122,361,000,000
1,056,088,000,000
1,053,700,000,000
1,052,299,000,000
1,046,542,000,000
1,044,570,000,000
1,044,766,000,000
1,045,756,000,000
1,056,909,000,000
1,036,056,000,000
1,054,616,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.